An Exceptional Response to Dostarlimab in Mismatch Repair Deficient, Microsatellite Instability-High and Platinum Refractory Endometrial Cancer

Until recently, effective therapies for advanced endometrial cancer progressing to a platinum-based combination were lacking. In this setting, immunotherapy with anti PD-1/PDL-1 monoclonal antibodies is rising as a new paradigm in particular for patients with microsatellites instability/mismatch rep...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Michele Bartoletti, Giorgio Giorda, Alessandra Viel, Mara Fornasarig, Adrian Zdjelar, Enrica Segatto, Roberto Sorio, Serena Corsetti, Simona Scalone, Milena Sabrina Nicoloso, Tania Pivetta, Emilio Lucia, Nicolò Clemente, Elisa Palazzari, Vincenzo Canzonieri, Fabio Puglisi
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	MDPI AG 2022-07-01
Ráidu:	Current Oncology
Fáttát:	endometrial cancer dostarlimab immunotherapy predictive biomarkers
Liŋkkat:	https://www.mdpi.com/1718-7729/29/8/413
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!